Pharmaleads presents a poster in collaboration with Emily Jutkiewicz, University of Michigan, USA on the latest preclinical results demonstrating the lack of abuse potential of PL37 and PL265, a new class of painkillers devoid of abuse potential and of opiate side-effects.
